PERICOLINI, Eva
 Distribuzione geografica
Continente #
NA - Nord America 13.849
AS - Asia 7.191
EU - Europa 6.616
SA - Sud America 1.017
AF - Africa 195
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 9
Totale 28.932
Nazione #
US - Stati Uniti d'America 13.516
SG - Singapore 2.209
GB - Regno Unito 1.823
IT - Italia 1.793
CN - Cina 1.660
HK - Hong Kong 819
BR - Brasile 739
VN - Vietnam 709
DE - Germania 553
SE - Svezia 500
BD - Bangladesh 355
RU - Federazione Russa 282
FR - Francia 277
UA - Ucraina 259
FI - Finlandia 251
IN - India 235
TR - Turchia 231
KR - Corea 226
ID - Indonesia 202
PL - Polonia 160
CA - Canada 159
BG - Bulgaria 120
MX - Messico 108
AR - Argentina 92
IQ - Iraq 81
RO - Romania 80
NL - Olanda 74
JP - Giappone 73
ZA - Sudafrica 63
BE - Belgio 62
ES - Italia 50
MY - Malesia 48
EC - Ecuador 45
IE - Irlanda 45
PK - Pakistan 44
AU - Australia 43
CL - Cile 43
AE - Emirati Arabi Uniti 42
HU - Ungheria 42
LT - Lituania 42
AT - Austria 41
IR - Iran 39
CO - Colombia 34
PT - Portogallo 31
EG - Egitto 29
CH - Svizzera 26
MA - Marocco 25
PE - Perù 25
TH - Thailandia 25
UZ - Uzbekistan 25
NO - Norvegia 22
PH - Filippine 21
IL - Israele 20
DZ - Algeria 18
CZ - Repubblica Ceca 17
SA - Arabia Saudita 16
TW - Taiwan 16
PY - Paraguay 15
VE - Venezuela 15
JM - Giamaica 13
AZ - Azerbaigian 12
NP - Nepal 12
DO - Repubblica Dominicana 11
GR - Grecia 11
JO - Giordania 11
KE - Kenya 11
TN - Tunisia 11
NZ - Nuova Zelanda 10
BB - Barbados 9
DK - Danimarca 9
KW - Kuwait 8
OM - Oman 8
SK - Slovacchia (Repubblica Slovacca) 8
CR - Costa Rica 7
BO - Bolivia 6
ET - Etiopia 6
GT - Guatemala 6
LB - Libano 6
LV - Lettonia 6
PA - Panama 6
UG - Uganda 6
KG - Kirghizistan 5
QA - Qatar 5
RS - Serbia 5
AL - Albania 4
CG - Congo 4
CI - Costa d'Avorio 4
HN - Honduras 4
LK - Sri Lanka 4
MT - Malta 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
GH - Ghana 3
Totale 28.880
Città #
Singapore 1.580
Santa Clara 1.540
Fairfield 1.343
Ashburn 1.305
Southend 1.065
Woodbridge 787
Hong Kong 778
Chandler 631
Houston 574
San Jose 555
Council Bluffs 521
Seattle 491
Wilmington 422
Jacksonville 388
Hefei 383
Cambridge 382
Dearborn 380
Beijing 374
London 319
Ann Arbor 311
Nyköping 262
Modena 257
Ho Chi Minh City 217
New York 215
Los Angeles 207
Seoul 201
Hanoi 157
The Dalles 155
Helsinki 146
Milan 146
Jakarta 138
San Diego 122
Sofia 113
Dallas 109
Buffalo 104
Princeton 103
Kraków 101
Bremen 99
Lauterbourg 99
Eugene 91
Bologna 89
Moscow 83
Rome 81
Chicago 79
Redwood City 75
São Paulo 74
Orem 71
Izmir 64
Tokyo 62
Timisoara 57
Carpi 56
Chennai 54
Exeter 54
Shanghai 54
Reggio Emilia 53
Nuremberg 50
Boardman 45
Haiphong 42
Munich 42
Guangzhou 41
Frankfurt am Main 40
Phoenix 40
Warsaw 40
Columbus 39
Johannesburg 38
Nanjing 38
Parma 38
Da Nang 37
Dublin 37
Mexico City 37
Toronto 37
Montreal 33
Atlanta 32
Dong Ket 32
Brooklyn 31
Brussels 31
Verona 31
Porto Alegre 29
Salt Lake City 29
Baghdad 28
Denver 28
Mumbai 28
Perugia 28
Amsterdam 25
Stockholm 25
Trieste 25
Florence 24
Poplar 24
San Francisco 24
Boston 23
Dongguan 23
Falls Church 23
Norwalk 23
Rio de Janeiro 23
Kent 22
Lappeenranta 21
Basingstoke 20
Istanbul 20
Tashkent 20
Wuhan 20
Totale 19.563
Nome #
Zinc treatment prevents neutrophil recruitment and inflammation by blocking Candida albicans Pra1 during vulvovaginal candidiasis. 857
Evaluation of benzydamine effects on Candida albicans adhesion, biofilm formation and persistence onto abiotic surfaces 481
Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response 448
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 391
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 387
In vitro effects of commercial mouthwashes on several virulence traits of Candida albicans, viridans streptococci and Enterococcus faecalis colonizing the oral cavity. 367
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 366
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 352
Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro 349
Antibody Constant Region Peptides Can Display Immunomodulatory Activity through Activation of the Dectin-1 Signalling Pathway 340
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 340
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 338
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 329
Effects of different mouthwashes on biofilm formation by oral streptococci 325
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 318
In vitro analysis of epithelial tolerability and anti-Candida effect of a new lactic acid-based vaginal gel formulation 317
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 310
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 310
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 307
Antibacterial Effects of MicroRepair®BIOMA-Based Toothpaste and Chewing Gum on Orthodontic Elastics Contaminated In Vitro with Saliva from Healthy Donors: A Pilot Study 306
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 303
Effects of different mouthwashes on Candida albicans adhesion, susceptibility to phagocytic cells and capacity to elicit pro-inflammatory cytokine response 302
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 296
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration 293
A Purified Capsular Polysaccharide Markedly Inhibits Inflammatory Response during Endotoxic Shock 293
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 284
Antibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity 282
Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice 273
Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro 271
Mouse Strain-Dependent Differences in Estrogen Sensitivity During Vaginal Candidiasis 270
Hyphal morphology, molecular genetics and phylogenetic relationships among commensal and pathogenic vulvovaginal isolates of Candida albicans 270
Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel Formulation: Novel Data Concerning Vaginal Infection and Dysbiosis 268
A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production 260
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis 260
Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence 257
The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection 254
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 253
A novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice 253
Functional Improvement of Regulatory T Cells From Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan 252
Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. 248
The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients 247
Peptides of the constant region of antibodies display fungicidal activity 241
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 240
Epitope unmasking in vulvovaginal candidiasis is associated with hyphal growth and neutrophilic infiltration. 238
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 238
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage 237
Inflammatory response during human vaginal infection with Candida albicans 237
Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy 236
NLRP3 inflammasome is a key player in human vulvovaginal disease caused by Candida albicans 235
Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression 234
An Untargeted Metabolomic Analysis of Lacticaseibacillus (L.) rhamnosus, Lactobacillus (L.) acidophilus, Lactiplantibacillus (L.) plantarum and Limosilactobacillus (L.) reuteri Reveals an Upregulated Production of Inosine from L. rhamnosus 228
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 227
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis 227
Experimental models of vaginal candidiasis and inflammation 222
Cryptococcus neoformans capsular polysaccharide component Galactoxylomannan induces apoptosis of human T cells through activation of Caspase-8 222
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 222
The Candida albicans Pra1 zincophore promotes neutrophils recruitment and inflammation during vulvovaginal candidiasis 222
A role for secretory aspartyl proteinase of Candida albicans in mouse vaginal inflammation and vaginal candidiasis 218
GILZ restrains neutrophil activation by inhibiting the MAPK pathway 217
Comparative analysis of commensal and pathogenic vulvovaginal clinical isolates of Candida albicans: hyphal morphology, molecular genetics and phylogenetic relationships 216
It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset 216
Saccharomyces cerevisiae as a new therapeutic agent against oropharyngeal candidiasis 215
Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis 211
THE PROTECTIVE ROLE OF TYPE-I INTERFERONS AXIS ACTIVATION IN THE VULVOVAGINAL CANDIDIASIS MODEL 209
Chronic vaginal candidiasis is achievable in outbred CD-1 mice 209
New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges 209
Involvement of glycoreceptors in galactoxylomannan-induced T cell death 209
Gray phenotype: enhanced fitness strategy for Candida dubliniensis 208
Elucidating the immunological function of the Cryptococcus neoformans capsule 203
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 203
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response. 200
A role for Cryptococcus neoformans galactoxylomannan in T cell apoptosis and function. 200
Aspartyl proteinases of Candida albicans induce caspase-11: implication in promoting inflammatory response 200
A microbial polysaccharide promotes selective elimination of pathogenic T cells from peripheral blood of rheumatoid arthritis patients by apoptosis induction. 200
Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor 199
Indinavir influences biological function of dendritic cells and stimulates antifungal immunity 197
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 196
Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro 195
Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts 194
In vivo induction of neutrophils chemotaxis by secretory aspartyl proteinases of Candida albicans 192
Candidalysin is a key player in activating vaginal cell ROS in an in vitro infection model 191
Secretory aspartyl-proteinases of Candida albicans contribute to severe inflammation observed in the course of vaginal candidiasis 191
Evaluation of Anti-Candida Activity of Vitis vinifera L. Seed Extracts Obtained from Wine and Table Cultivars 191
The GITRL-GITR system alters TLR-4 expression on DC during fungal infection 190
Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome 190
A microbial polysaccharide reduces the severity of rheumatoid arthtritis via inhibition of Th17 differentiation 189
Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages 189
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 188
The Propionibacterium spp. extract reduces Candida albicans-induced damage to vaginal epithelial cells and increases mitochondrial response to Candida albicans infection in vitro 187
A new strategy to prevent biofilm and clot formation in medical devices: the use of atmospheric non-thermal plasma assisted deposition of silver-based nanostructured coatings 184
Cell-Free Supernatant from a Strain of Bacillus siamensis Isolated from the Skin Showed a Broad Spectrum of Antimicrobial Activity 183
Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages 182
Therapeutic activity of Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis 180
The pathogenic and colonization potential of Candida africana 177
Any antibody fragment might exert antifungal activity 176
Comparison between bioluminescence imaging technique and CFU count for the study of oropharyngeal candidiasis in mice 176
In vivo colonization and pathogenic potential of C. africana 175
Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection 172
Cutibacterium acnes lysate improves cellular response against Candida albicans, Escherichia coli and Gardnerella vaginalis in an in vitro model of vaginal infection 169
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 166
Totale 25.295
Categoria #
all - tutte 102.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/20221.936 134 206 273 91 46 98 103 92 197 166 330 200
2022/20232.193 181 161 202 203 293 272 67 212 298 62 122 120
2023/20241.961 80 124 147 123 244 251 142 252 73 163 149 213
2024/20255.335 200 120 127 394 1.165 850 266 365 519 383 430 516
2025/20269.825 542 380 572 1.171 1.275 706 1.168 559 935 1.071 879 567
Totale 29.197